The Influence Factors of Bispectral Index Values Increment Caused by Sugammadex

CompletedOBSERVATIONAL
Enrollment

135

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

September 13, 2024

Study Completion Date

September 14, 2024

Conditions
BIS
Interventions
DRUG

Sugammadex administration

After surgery was completed while the train-of-four ratio was zero, a steady-state intravenous anesthesia was maintained to keep a BIS value within the range of 40-60 for at least 5 minutes. Patients received sugammadex 2 mg.kg-1 after completed surgery.

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Jun Zhang

OTHER

NCT06561633 - The Influence Factors of Bispectral Index Values Increment Caused by Sugammadex | Biotech Hunter | Biotech Hunter